Trial Profile
A double-blind randomized placebo controlled study of quetiapine for the treatment of depression in adolescents with bipolar disorder.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar depression; Bipolar I disorders
- Focus Therapeutic Use
- 26 Oct 2007 Status changed from recruiting to completed
- 04 Nov 2006 New trial record.